Funders › CA › Pediatric Cancer Research Foundation › 2024
Grants paid by Pediatric Cancer Research Foundation, tax year 2024
EIN 95-3772528 · Irvine, CA · Form 990, Schedule I
In tax year 2024, Pediatric Cancer Research Foundation (EIN 95-3772528) reported 14 grants paid totaling $824,563. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | New York Medical College Valhalla, NY | A | $275,000 | paid | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE | 202521079349301112 |
| 2024 | Memorial Sloan Kettering New York, NY | A | $75,000 | paid | TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS | 202521079349301112 |
| 2024 | City of Hope Duarte, CA | U | $50,000 | paid | SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | 202521079349301112 |
| 2024 | Dana Farber Boston, MA | A | $50,000 | paid | PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA | 202521079349301112 |
| 2024 | Stanford University Palo Alto, CA | A | $50,000 | paid | TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML | 202521079349301112 |
| 2024 | Johns Hopkins University Baltimore, MD | A | $50,000 | paid | TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA | 202521079349301112 |
| 2024 | Hope for Henry Washington, DC | A | $49,563 | paid | REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE | 202521079349301112 |
| 2024 | Ucsf San Francisco, CA | A | $40,000 | paid | TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA | 202521079349301112 |
| 2024 | Children's Hospital of Los Angeles Los Angeles, CA | A | $37,500 | paid | PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS | 202521079349301112 |
| 2024 | Case Western Clevenland, OH | A | $37,500 | paid | USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS | 202521079349301112 |
| 2024 | Indiana University Bloomington, IN | A | $30,000 | paid | DECODING METABOLIC DEPENDENCIES OF MPNSTS AND ITS MICROENVIRONMENT | 202521079349301112 |
| 2024 | Children's Hospital of Philadelphia Philadelphia, PA | A | $30,000 | paid | ELUCIDATING HOW NF1 LOSS COOPERATES WITH SETD2 TO DRIVE PEDIATRIC HIGH-GRADE GLIOMA FORMATION | 202521079349301112 |
| 2024 | City of Hope Duarte, CA | U | $25,000 | paid | REPORTER T CELL LINE GENERATION | 202521079349301112 |
| 2024 | Children's Hospital of Los Angeles Los Angeles, CA | A | $25,000 | paid | PROJECT TO LEVERAGE THE POWER OF THE IMMUNE SYSTEM TO FIGHT PEDIATRIC HIGH-GRADE GLIOMA | 202521079349301112 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.